DA-5210 10/500mg

DRUG2 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Healthy

Phase 1

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

CompletedNCT05098262

Dong-A ST Co., Ltd.Healthy

Start: 2021-10-31End: 2022-01-03Updated: 2022-06-06

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State

CompletedNCT05098275

Dong-A ST Co., Ltd.Healthy

Start: 2021-10-26End: 2022-02-06Updated: 2022-06-06